Migraine Market Report

China Migraine Industry Market Research Report 2023-2029

  • POSTDATE：Sep 07, 2023
  • PAGES：174
  • REPORT CODE：GMM1781932
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Migraine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis AG

    • Sanofi SA

    • Bausch Health Companies Inc

    • Johnson & Johnson

    • Amgen Inc

    • Merck & Co

    • Teva

    • AstraZeneca Plc

    • Pfizer

    • Eli Lilly and Company

    • Eisai Co Ltd

    • Allergan

    • Abbott Laboratories

    By Type:

    • Triptans

    • Ditans

    • NSAIDs

    • CGRP small molecule antagonists

    • Others

    • Acetylcholine Inhibitors

    • Ergot Alkaloids

    • CGRP monoclonal antibodies

    By Application:

    • Retail Pharmacies

    • Hospital-Based Pharmacies

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Migraine Market Overview 2018-2029

    • 1.1 China Migraine Industry Development Overview

    • 1.2 China Migraine Industry Development History

    • 1.3 China Migraine Industry Market Size (2018-2029)

    • 1.4 China Migraine Market Analysis by Type from Production Side

      • 1.4.1 China Migraine Production Volume, Production Value and Growth Rate of Triptans (2018-2029)

      • 1.4.2 China Migraine Production Volume, Production Value and Growth Rate of Ditans (2018-2029)

      • 1.4.3 China Migraine Production Volume, Production Value and Growth Rate of NSAIDs (2018-2029)

      • 1.4.4 China Migraine Production Volume, Production Value and Growth Rate of CGRP small molecule antagonists (2018-2029)

      • 1.4.5 China Migraine Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.6 China Migraine Production Volume, Production Value and Growth Rate of Acetylcholine Inhibitors (2018-2029)

      • 1.4.7 China Migraine Production Volume, Production Value and Growth Rate of Ergot Alkaloids (2018-2029)

      • 1.4.8 China Migraine Production Volume, Production Value and Growth Rate of CGRP monoclonal antibodies (2018-2029)

    • 1.5 China Migraine Market Analysis by Application from Consumption End

      • 1.5.1 China Migraine Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.2 China Migraine Sales Volume, Sales Value and Growth Rate of Hospital-Based Pharmacies (2018-2029)

      • 1.5.3 China Migraine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Migraine Market Analysis by Region

      • 1.6.1 North China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Migraine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Migraine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Migraine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Migraine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Migraine Market Status and Competition Analysis in 2023

      • 2.2.3 China Migraine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Migraine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Migraine Industry Development

    Chapter 3 MigraineIndustry Chain Analysis

    • 3.1 Migraine Industry Chain

    • 3.2 Migraine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Migraine Market

    • 3.3 Migraine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Migraine Market

    Chapter 4 China Migraine Market, by Type

    • 4.1 China Migraine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Migraine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Migraine Production Volume and Growth Rate, by Type

      • 4.5.1 China Migraine Production Volume and Growth Rate of Triptans

      • 4.5.2 China Migraine Production Volume and Growth Rate of Ditans

      • 4.5.3 China Migraine Production Volume and Growth Rate of NSAIDs

      • 4.5.4 China Migraine Production Volume and Growth Rate of CGRP small molecule antagonists

      • 4.5.5 China Migraine Production Volume and Growth Rate of Others

      • 4.5.6 China Migraine Production Volume and Growth Rate of Acetylcholine Inhibitors

      • 4.5.7 China Migraine Production Volume and Growth Rate of Ergot Alkaloids

      • 4.5.8 China Migraine Production Volume and Growth Rate of CGRP monoclonal antibodies

    Chapter 5 China Migraine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Migraine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Migraine Market Size and Growth Rate, by Application

      • 5.5.1 China Migraine Market Size and Growth Rate of Retail Pharmacies

      • 5.5.2 China Migraine Market Size and Growth Rate of Hospital-Based Pharmacies

      • 5.5.3 China Migraine Market Size and Growth Rate of Others

    Chapter 6 China Migraine Market, by Region

    • 6.1 China Migraine Production Volume and Production Value, by Region

    • 6.2 China Migraine Sales Volume and Sales Value, by Region

    Chapter 7 North China Migraine Market Analysis

    • 7.1 North China Migraine Market, by Type

    • 7.2 North China Migraine Market, by Application

    Chapter 8 Central China Migraine Market Analysis

    • 8.1 Central China Migraine Market, by Type

    • 8.2 Central China Migraine Market, by Application

    Chapter 9 South China Migraine Market Analysis

    • 9.1 South China Migraine Market, by Type

    • 9.2 South China Migraine Market, by Application

    Chapter 10 East China Migraine Market Analysis

    • 10.1 East China Migraine Market, by Type

    • 10.2 East China Migraine Market, by Application

    Chapter 11 Northeast China Migraine Market Analysis

    • 11.1 Northeast China Migraine Market, by Type

    • 11.2 Northeast China Migraine Market, by Application

    Chapter 12 Southwest China Migraine Market Analysis

    • 12.1 Southwest China Migraine Market, by Type

    • 12.2 Southwest China Migraine Market, by Application

    Chapter 13 Northwest China Migraine Market Analysis

    • 13.1 Northwest China Migraine Market, by Type

    • 13.2 Northwest China Migraine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis AG

        • 14.1.1 Novartis AG Company Profile

        • 14.1.2 Novartis AG Migraine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi SA

        • 14.2.1 Sanofi SA Company Profile

        • 14.2.2 Sanofi SA Migraine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bausch Health Companies Inc

        • 14.3.1 Bausch Health Companies Inc Company Profile

        • 14.3.2 Bausch Health Companies Inc Migraine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Johnson & Johnson

        • 14.4.1 Johnson & Johnson Company Profile

        • 14.4.2 Johnson & Johnson Migraine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Amgen Inc

        • 14.5.1 Amgen Inc Company Profile

        • 14.5.2 Amgen Inc Migraine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck & Co

        • 14.6.1 Merck & Co Company Profile

        • 14.6.2 Merck & Co Migraine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Teva

        • 14.7.1 Teva Company Profile

        • 14.7.2 Teva Migraine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca Plc

        • 14.8.1 AstraZeneca Plc Company Profile

        • 14.8.2 AstraZeneca Plc Migraine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer

        • 14.9.1 Pfizer Company Profile

        • 14.9.2 Pfizer Migraine Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lilly and Company

        • 14.10.1 Eli Lilly and Company Company Profile

        • 14.10.2 Eli Lilly and Company Migraine Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Eisai Co Ltd

        • 14.11.1 Eisai Co Ltd Company Profile

        • 14.11.2 Eisai Co Ltd Migraine Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Allergan

        • 14.12.1 Allergan Company Profile

        • 14.12.2 Allergan Migraine Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Abbott Laboratories

        • 14.13.1 Abbott Laboratories Company Profile

        • 14.13.2 Abbott Laboratories Migraine Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Migraine Industry Research Conclusions

    • 15.2 Migraine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Migraine Industry Market Size (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of Triptans (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of Ditans (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of NSAIDs (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of CGRP small molecule antagonists (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of Acetylcholine Inhibitors (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of Ergot Alkaloids (2018-2029)

    • Figure China Migraine Production Volume, Production Value and Growth Rate of CGRP monoclonal antibodies (2018-2029)

    • Figure China Migraine Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Migraine Sales Volume, Sales Value and Growth Rate of Hospital-Based Pharmacies (2018-2029)

    • Figure China Migraine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Migraine Market Size and Growth Rate from 2018-2029

    • Figure Central China Migraine Market Size and Growth Rate from 2018-2029

    • Figure South China Migraine Market Size and Growth Rate from 2018-2029

    • Figure East China Migraine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Migraine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Migraine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Migraine Market Size and Growth Rate from 2018-2029

    • Figure Migraine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Migraine Market Share by Type in 2018

    • Figure China Migraine Market Share by Type in 2023

    • Figure China Migraine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of Triptans (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of Ditans (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of NSAIDs (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of CGRP small molecule antagonists (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of Acetylcholine Inhibitors (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of Ergot Alkaloids (2018-2023)

    • Figure China Migraine Production Volume and Growth Rate of CGRP monoclonal antibodies (2018-2023)

    • Figure China Migraine Market Share by Application in 2018

    • Figure China Migraine Market Share by Application in 2023

    • Figure China Migraine Total Market Size and Growth Rate from Consumption End

    • Figure China Migraine Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Migraine Market Size and Growth Rate of Hospital-Based Pharmacies (2018-2023)

    • Figure China Migraine Market Size and Growth Rate of Others (2018-2023)

    • Table China Migraine Production Volume by Region (2018-2023)

    • Table China Migraine Production Volume Share by Region (2018-2023)

    • Figure China Migraine Production Volume Share by Region (2018-2023)

    • Table China Migraine Production Value by Region (2018-2023)

    • Table China Migraine Production Value Share by Region (2018-2023)

    • Figure China Migraine Production Value Share by Region (2018-2023)

    • Table China Migraine Sales Volume by Region (2018-2023)

    • Table China Migraine Sales Volume Share by Region (2018-2023)

    • Figure China Migraine Sales Volume Share by Region (2018-2023)

    • Table China Migraine Sales Value by Region (2018-2023)

    • Table China Migraine Sales Value Share by Region (2018-2023)

    • Figure China Migraine Sales Value Share by Region (2018-2023)

    • Table North China Migraine Production Volume by Type (2018-2023)

    • Table North China Migraine Production Volume Share by Type (2018-2023)

    • Figure North China Migraine Production Volume Share by Type (2018-2023)

    • Table North China Migraine Sales Volume by Application (2018-2023)

    • Table North China Migraine Sales Volume Share by Application (2018-2023)

    • Figure North China Migraine Sales Volume Share by Application (2018-2023)

    • Table Central China Migraine Production Volume by Type (2018-2023)

    • Table Central China Migraine Production Volume Share by Type (2018-2023)

    • Figure Central China Migraine Production Volume Share by Type (2018-2023)

    • Table Central China Migraine Sales Volume by Application (2018-2023)

    • Table Central China Migraine Sales Volume Share by Application (2018-2023)

    • Figure Central China Migraine Sales Volume Share by Application (2018-2023)

    • Table South China Migraine Production Volume by Type (2018-2023)

    • Table South China Migraine Production Volume Share by Type (2018-2023)

    • Figure South China Migraine Production Volume Share by Type (2018-2023)

    • Table South China Migraine Sales Volume by Application (2018-2023)

    • Table South China Migraine Sales Volume Share by Application (2018-2023)

    • Figure South China Migraine Sales Volume Share by Application (2018-2023)

    • Table East China Migraine Production Volume by Type (2018-2023)

    • Table East China Migraine Production Volume Share by Type (2018-2023)

    • Figure East China Migraine Production Volume Share by Type (2018-2023)

    • Table East China Migraine Sales Volume by Application (2018-2023)

    • Table East China Migraine Sales Volume Share by Application (2018-2023)

    • Figure East China Migraine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Migraine Production Volume by Type (2018-2023)

    • Table Northeast China Migraine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Migraine Production Volume Share by Type (2018-2023)

    • Table Northeast China Migraine Sales Volume by Application (2018-2023)

    • Table Northeast China Migraine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Migraine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Migraine Production Volume by Type (2018-2023)

    • Table Southwest China Migraine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Migraine Production Volume Share by Type (2018-2023)

    • Table Southwest China Migraine Sales Volume by Application (2018-2023)

    • Table Southwest China Migraine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Migraine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Migraine Production Volume by Type (2018-2023)

    • Table Northwest China Migraine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Migraine Production Volume Share by Type (2018-2023)

    • Table Northwest China Migraine Sales Volume by Application (2018-2023)

    • Table Northwest China Migraine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Migraine Sales Volume Share by Application (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Migraine Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Migraine Revenue, Price and Gross (2018-2023)

    • Table Bausch Health Companies Inc Company Profile

    • Table Bausch Health Companies Inc Migraine Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Migraine Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Migraine Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co Migraine Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Migraine Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc Migraine Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Migraine Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Migraine Revenue, Price and Gross (2018-2023)

    • Table Eisai Co Ltd Company Profile

    • Table Eisai Co Ltd Migraine Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Migraine Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Migraine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US